Multikinase inhibitors are a class of drugs that target multiple kinase enzymes involved in the signaling pathways that regulate cell growth and survival, making them effective in treating various cancers. By inhibiting multiple kinases, these drugs can overcome resistance mechanisms that limit the efficacy of single-target therapies.